Refine
Year of publication
Document Type
- Article (819)
- Preprint (717)
- Conference Proceeding (7)
- Part of Periodical (4)
- Working Paper (3)
- Book (2)
- Course Material (1)
Has Fulltext
- yes (1553)
Is part of the Bibliography
- no (1553)
Keywords
- Heavy Ion Experiments (21)
- breast cancer (13)
- Mammakarzinom (12)
- glioblastoma (12)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Behandlung (8)
- Metastasen (8)
- CDK4/6 (6)
- Heavy-ion collision (6)
- PD1/PDL1 (6)
- Prävention (6)
- Studien (6)
- prevention (6)
- schizophrenia (6)
- treatment (6)
- MRI (5)
- metastases (5)
- risk (5)
- ALICE experiment (4)
- Collective Flow (4)
- Glioblastoma (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- Risiko (4)
- glioma (4)
- hypoxia (4)
- immunotherapy (4)
- trials (4)
- ALICE (3)
- Breast cancer (3)
- EGFR (3)
- Elastic scattering (3)
- Heavy Ions (3)
- Heavy Quark Production (3)
- Jets and Jet Substructure (3)
- PDGFRβ (3)
- Relativistic heavy-ion collisions (3)
- bevacizumab (3)
- biomarker (3)
- chemotherapy (3)
- chimeric antigen receptor (3)
- cirrhosis (3)
- cytokine-induced killer cells (3)
- global change (3)
- meningioma (3)
- metastatic (3)
- neoadjuvant therapy (3)
- pp collisions (3)
- stroke (3)
- targeted therapy (3)
- Alpelisib (2)
- Atezolizumab (2)
- Beauty production (2)
- CIK cells (2)
- COPD (2)
- COVID-19 (2)
- CRM (2)
- Charm physics (2)
- Critical care (2)
- Diagnostik (2)
- Diffraction (2)
- Drug therapy (2)
- Elliptic flow (2)
- Epilepsy (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Extended donor criteria (2)
- Fasting (2)
- Früherkennung (2)
- Galaktografie (2)
- Galaktomosynthese (2)
- Genetics (2)
- Genetics research (2)
- Glucose (2)
- HER2/neu (2)
- Heavy-ion collisions (2)
- IDH mutation (2)
- Immunology (2)
- KGF (2)
- Katherine (2)
- Ketogenic diet (2)
- Leptin (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Lokalrezidiv (2)
- MEG (2)
- MRT (2)
- Machine learning (2)
- Malaria (2)
- Mamma (2)
- NK-92 (2)
- Nachsorge (2)
- PARP (2)
- PD-1 (2)
- PD-L1 (2)
- PD1/ PDL1 (2)
- PD‑L1 (2)
- PI3K (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Peritonitis (2)
- Personalized medicine (2)
- Polarization (2)
- Predictive markers (2)
- Prognosefaktoren (2)
- Prädiktivfaktoren (2)
- Psychiatric disorders (2)
- Pulmonary embolism (2)
- QCD (2)
- Quarkonium (2)
- RHIC (2)
- ROS (2)
- Radiation (2)
- Radiotherapy (2)
- Richtlinie (2)
- Sestrin 2 (2)
- Single electrons (2)
- Supportivtherapie (2)
- Surgery (2)
- Targeted therapy (2)
- Temozolomide (2)
- Tomosynthese (2)
- T‑DM1 (2)
- Ultraschall (2)
- adjuvant therapy (2)
- adjuvante Therapie (2)
- adult (2)
- advanced (2)
- allogeneic stem cell transplantation (2)
- alpelisib (2)
- anaemia (2)
- anti-angiogenic therapy (2)
- atezolizumab (2)
- biodiversity protection (2)
- brain metastases (2)
- brain metastasis (2)
- breast (2)
- composite structures (2)
- conservation funding (2)
- conservation planning (2)
- decision making (2)
- diagnosis (2)
- early breast cancer (2)
- follow‑up (2)
- fortgeschritten (2)
- frühes Mammakarzinom (2)
- galactography (2)
- galactomosynthesis (2)
- genome (2)
- guideline (2)
- local recurrence (2)
- mTOR (2)
- mitochondria (2)
- neoadjuvante Therapie (2)
- neural oscillations (2)
- post-2020 biodiversity targets (2)
- predictive factors (2)
- prognostic factors (2)
- screening (2)
- starvation (2)
- strategic site selection (2)
- studies (2)
- supportive therapy (2)
- tomosynthesis (2)
- treatment/therapy (2)
- tumor microenvironment (2)
- ultrasound (2)
- 140Ce (1)
- 19F MR spectroscopy (1)
- 1H MR spectroscopy (1)
- 2-deoxyglucose (2-DG) (1)
- 2-hydroxyglutarate (1)
- 4-1BB (1)
- 900 GeV (1)
- AB-serum (1)
- ABC transporters (1)
- ALICE detector (1)
- AML (1)
- APP processing (1)
- APRI (1)
- ARDS (1)
- ATPases (1)
- Active middle ear implants (1)
- Acute cough (1)
- Acute myeloid leukemia (1)
- Addison’s disease (1)
- Advanced biliary tract cancer (1)
- Advanced breast cancer (1)
- Adverse events (1)
- Aiolochroia crassa (1)
- Alien (1)
- All-trans retinoic acid (1)
- Allogeneic hematopoietic stem (1)
- Alzheimer (1)
- Ambroxol (1)
- Aneurysmal subarachnoid hemorrhage (1)
- Angiogenesis (1)
- Anti-nuclei (1)
- Antihormone therapy (1)
- Appendectomy (1)
- Appendicitis (1)
- Artemether-lumefantrine (1)
- Artemisinin-combination-therapy (1)
- Artenschutz (1)
- Artesunate (1)
- Artificial Intelligence (1)
- Asset Purchase Programme (1)
- Astrocytoma (1)
- Auditory system (1)
- B cell malignancies (1)
- B-slope (1)
- BEACOPP (1)
- BRAF (1)
- BRAF V600E (1)
- BTC (1)
- Baryonic resonances (1)
- Bevacizumab (1)
- Big Data (1)
- Biodiversity (1)
- Biodiversity Data (1)
- Biodiversität (1)
- Biogeographical representativeness (1)
- Bioinformatics (1)
- Biological (1)
- Biomarker (1)
- Biomarkers (1)
- Biomonitoring (1)
- Biotopschutz (1)
- Bipolar disorder (1)
- Blood-brain barrier (1)
- Bone conduction devices (1)
- Bone metastases (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Brain metastasis (1)
- Brain tumor (1)
- Burkholderia arboris (1)
- Business strategy in drug development (1)
- C5 acylcarnitine (1)
- CAR (1)
- CD137 (1)
- CD3/CD19 depletion (1)
- CD74 (1)
- CDI (1)
- CDK4/CDK6 (1)
- COVID (1)
- CTLA-4 (1)
- CVD biomarker (1)
- CVID (1)
- CYP450 (1)
- Cancer (1)
- Cancer genomics (1)
- Candida (1)
- Cardiomyocyte signaling pathways (1)
- Cardioprotection (1)
- Cardiovascular disease (1)
- Cell biology (1)
- Cell membranes (1)
- Central Bank Communication (1)
- Central nervous system metastases (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge fluctuations (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charmonia (1)
- Cherenkov counter: lead-glass (1)
- Chimerism (1)
- Circadian (1)
- Cleanliness level (1)
- Clinical genetics (1)
- Clinical study (1)
- Closure (1)
- Coalescence (1)
- Cold nuclear matter effects (1)
- Collective Flow, (1)
- Collectivity (1)
- Colon capsule endoscopy (1)
- Comorbidities (1)
- Comparison with QCD (1)
- Complementation rate (1)
- Complicated appendicitis (1)
- Consensus statement (1)
- Conservation (1)
- Coronary heart disease (1)
- Correlation (1)
- Covid19-nmr (1)
- Critical point (1)
- Cytoskeleton (1)
- DDIT4 (1)
- DEE (1)
- DNA methylation (1)
- DST (1)
- Data management (1)
- Data sharing (1)
- Decision trees (1)
- Depression (1)
- Deuteron production (1)
- Dexamethasone (1)
- Di-hadron correlations (1)
- Diagnostic differentiation (1)
- Diagnostic markers (1)
- Diesel (1)
- Digitization (1)
- Direct oral anticoagulation (1)
- Drug susceptibility testing (1)
- Drug targeting (1)
- E/I-Balance (1)
- EBV (1)
- EET (1)
- EGFR inhibitor (1)
- EGFRvIII mutation (1)
- EMT (1)
- ERBB2 (1)
- ERBB2 (HER2/neu) (1)
- Ecosystem integrity (1)
- Ecosystems (1)
- Edema (1)
- Edition (1)
- Electromagnetic transitions (1)
- Electron-pion identification (1)
- Electronic properties and materials (1)
- Electrophysiology (1)
- Electroweak interaction (1)
- Emotions (1)
- Endothelial permeability (1)
- Entomology (1)
- Environment (1)
- Epidemiology (1)
- Epidermal growth factor receptor (1)
- Epstein-Barr virus (1)
- Essential biodiversity variables (1)
- Europe (1)
- European Society for Immunodeficiencies (ESID) (1)
- Ewing sarcoma (1)
- Exosomes (1)
- Extended Glasgow outcome scale (eGOS) (1)
- Extracellular RNA (eRNA) (1)
- FFPE (1)
- FIB-4 (1)
- Falciparum (1)
- Fc receptor (1)
- Femtoscopy (1)
- Ferroelectrics and multiferroics (1)
- Fibre/foam sandwich radiator (1)
- Fibrosis (1)
- Filgrastim (1)
- First site of metastatic disease (1)
- Fistula (1)
- Flow (1)
- Forward Guidance (1)
- Frankfurt am Main (1)
- Freezeout (1)
- Gadobutrol (1)
- Gadopentate dimeglumine (1)
- Gamma-Band Activity (1)
- Gene regulation (1)
- German PID-NET registry (1)
- Glioblastoma survival (1)
- Glioma (1)
- Grading (1)
- Graft function (1)
- Graft survival (1)
- Groomed jet radius (1)
- Guanine nucleotide exchange factors (1)
- Guanosine triphosphatase (1)
- Guided waves (1)
- Guidelines (1)
- HADES (1)
- HBT (1)
- HBV (1)
- HER2 c-erbB2 (1)
- HER2-positive (1)
- HIPPO signalling (1)
- HLA class II (1)
- HLA peptidome (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hadronization (1)
- Hand-foot syndrome (1)
- Hard Scattering (1)
- Head and neck cancer (1)
- Health policy (1)
- Healthy stem cell donors (1)
- Heart regeneration (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ion collisions (1)
- Heavy ions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion (1)
- Heavy-ion reactions (1)
- Hepatitis C virus (1)
- Herbaria (1)
- Heregulin (1)
- Hif-1 alpha (1)
- Hif1α (1)
- Higher moments (1)
- Hippocampus (1)
- Human behaviour (1)
- Hyperons (1)
- IDH1 inhibitor (1)
- IL-15 (1)
- IL-21 (1)
- IVA interference tandem mass spectrometry (1)
- IgG substitution therapy (1)
- IgGAM (1)
- Immunogenetics (1)
- Immunomodulatory agents (1)
- Inclusive spectra (1)
- Incomplete colonoscopy (1)
- Induced pluripotent stem cells (1)
- Induction chemotherapy (1)
- Influenza (1)
- Intensity interferometry (1)
- Interference fragmentation function (1)
- Intra-abdominal infection (1)
- Invariant Mass Distribution (1)
- Inverse kinematics (1)
- Ionisation energy loss (1)
- Ischemia–reperfusion injury (1)
- Isoflurane (1)
- Isoscalar giant resonances (1)
- Isoxazoline Alkaloids (1)
- J/ψ suppression (1)
- Jet Physics (1)
- Jet Substructure (1)
- Jet substructure (1)
- KCGS (1)
- KPS (1)
- Kreuzenzian (1)
- Kreuzenzian-Ameisenbläuling (1)
- LC3B (1)
- LTER (1)
- Laparoscopic appendectomy (1)
- Laparostomy (1)
- Laubmoss (1)
- Lebermoos (1)
- Lesion (1)
- Library screening (1)
- Lipid metabolism (1)
- Liver transplantation (1)
- London (1)
- Long term output (1)
- Long-term ecological monitoring (1)
- Long‐term ecosystem research (1)
- Low grade glioma (1)
- Low volume prep (1)
- Low-molecular-weight heparin (1)
- Luciferase (1)
- Lung cancer (1)
- Lymphocytes (1)
- Lymphoid tissues (1)
- M. Intracellulare (1)
- M. avium (1)
- M. avium complex (1)
- M. chimaera (1)
- MACS (1)
- MET (1)
- MGMT (1)
- MGMT promoter (1)
- MM-121 (1)
- MRI patterns of gliomas (1)
- Magnetic properties and materials (1)
- Magnetic resonance imaging (MRI) (1)
- Malariae (1)
- Malignant meningioma (1)
- Mammalian target of rapamycin (1)
- Marginal grafts (1)
- Material budget (1)
- Materials science (1)
- Medical imaging (1)
- Meningioma (1)
- Mental health and psychiatry (1)
- Mesh (1)
- Meta-analysis (1)
- Metabolism (1)
- Metastatic (1)
- MicroRNAs (1)
- MicroRNAs (miRNAs) (1)
- Mid-rapidity (1)
- Minimal residual disease (1)
- Minimum Bias (1)
- Mitochondria (1)
- Mixed hearing loss (1)
- Models & methods for nuclear reactions (1)
- Molecular biology (1)
- Molecular matched therapy (1)
- Molecular neuroscience (1)
- Molecular profiling (1)
- Molecular subtypes (1)
- Monte Carlo (1)
- Moviprep (1)
- Multi-Parton Interactions (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multiomics (1)
- Multiple parton interactions (1)
- Multivariate analysis (1)
- N-methyl-D-aspartate receptor (1)
- NADPH oxidase (1)
- NK cells (1)
- NMR spectroscopy (1)
- NSAIDs (1)
- NSCLC (1)
- NTM (1)
- Nanoscale materials (1)
- Neoadjuvant therapy (1)
- Neolithic (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Network analysis (1)
- Neural network (1)
- Neuropilin (1)
- Neuroscience (1)
- Neutron physics (1)
- Nimotuzumab (1)
- Non-falciparum (1)
- Non-interventional study (1)
- Non-trauma (1)
- Non-tuberculous mycobacteria (1)
- Nonflow (1)
- Noninferiority (1)
- Nox1 (1)
- NoxO1 (1)
- Nuclear Physics (1)
- Nuclear modification factor (1)
- Nuclear reactions (1)
- Nucleophosmin-1 (1)
- Nucleus (1)
- Nutrition (1)
- Obesity (1)
- Observation (1)
- Oligodendroglioma (1)
- Omics (1)
- Oncology (1)
- Open abdomen (1)
- Organ allocation (1)
- Organ rinse (1)
- Organ shortage (1)
- Osteoporosis (1)
- Outcome (1)
- Ovale (1)
- PID prevalence (1)
- PML (1)
- PTEN (1)
- PXA (1)
- PYTHIA (1)
- Paediatrics (1)
- Pancreas transplantation (1)
- Pancreatitis (1)
- Parainfluenza (1)
- Particle and Resonance Production (1)
- Pathological complete response (1)
- Pathology (1)
- Patterns of care (1)
- Pb–Pb (1)
- Pentaglobin (1)
- Pharmacy setting (1)
- Phase transitions and critical phenomena (1)
- Phospho-soda (1)
- Phosphorylation (1)
- Phylogenomics (1)
- Physical and mental health (1)
- Physiology (1)
- PillCamColon2 (1)
- Plasmodium (1)
- Pneumonia (1)
- Polyps (1)
- Population genetics (1)
- Pre-emptive immunotherapy (1)
- Predictive medicine (1)
- Production Cross Section (1)
- Prognostic models (1)
- Properties of Hadrons (1)
- Prostate cancer (1)
- Proton (1)
- Proton-proton collisions (1)
- Proton–proton (1)
- Proton–proton collisions (1)
- Pseudomonas aeruginosa (1)
- Psychiatry (1)
- Psychometrics (1)
- Pulmonary edema (1)
- Pyogenic spondylodiscitis (1)
- QGP (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Questionnaires (1)
- Quinine (1)
- RMS (1)
- RNA (1)
- RNA PT (1)
- RNA modification (1)
- Radiation necrosis (1)
- Radiative capture (1)
- Rapidity Range (1)
- Re-exploration (1)
- Reactive oxygen species (1)
- Red blood cell transfusion (1)
- Regression analysis (1)
- Rehabilitation (1)
- Reigen (1)
- Reintervention (1)
- Rejection (1)
- Relativistic heavy ion physics (1)
- Remote ischemic conditioning (1)
- Renal lesions (1)
- Research Article (1)
- Research Infrastructure (1)
- Research infrastructure (1)
- Resolution Parameter (1)
- Resonance reactions (1)
- Respiratory distress syndrome (1)
- Respiratory syncytial virus (1)
- Rheumatoid arthritis (1)
- Rheumatology (1)
- Risk factor (1)
- SARS-CoV-2 (1)
- SF-12 (1)
- SKALE score (1)
- SNP (1)
- STAMPE2 (1)
- STAR (1)
- SWATH (1)
- Salivary gland carcinoma (1)
- Schizophrenia (1)
- Schnitzler, Arthur (1)
- Seasonal variation (1)
- Semantics (1)
- Sepsis (1)
- Seribantumab (1)
- Severe bacterial infection (1)
- Severe malaria (1)
- Shear viscosity (1)
- Side effect (1)
- Single muons (1)
- Site networks (1)
- Small molecules (1)
- Socio-ecology (1)
- SoftDrop (1)
- Solar insolation (1)
- Sorafenib (1)
- Sozialpsychiatrischer Dienst (1)
- Spin alignment (1)
- Splitting function (1)
- Sponges (1)
- Stadtentwicklung (1)
- Stadtökonomie (1)
- Status epilepticus (1)
- Stem-cell therapies (1)
- Stentoplasty (1)
- Storage ring (1)
- Strangeness (1)
- Structure Elucidation (1)
- Suicide (1)
- Sunlight (1)
- Superinfection (1)
- Superoxide (1)
- Surgical oncology (1)
- Synaptic plasticity (1)
- Synthetic (1)
- Systematic Uncertainty (1)
- T-DM1 (1)
- TGF-β (1)
- TGFB-induced factor homeobox 1 (1)
- TGIF (1)
- TIRADS (1)
- TOR signalling (1)
- TR (1)
- TRPA1 (1)
- TTW nodules (1)
- Tacrolimus (1)
- Tailored medicine (1)
- Taxonomy (1)
- Technical data (1)
- Technique (1)
- Tet-inducible system (1)
- Therapeutic anticoagulation (1)
- Therapies (1)
- Thermal model (1)
- Time Projection Chamber (1)
- Timing (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Transversity (1)
- Trauma (1)
- Treatment outcome (1)
- Trigger (1)
- Triple negative (1)
- Tumor heterogeneity (1)
- Tumor infiltrating lymphocytes (1)
- Uncomplicated appendicitis (1)
- Unconventional Monetary Policy (1)
- Upper respiratory tract infection (1)
- VEGF (1)
- VEGF receptors (1)
- VEGFR (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Vascular emergencies (1)
- Vector Boson Production (1)
- Versorgungsstrukturen (1)
- Vertebral augmentation (1)
- Vertebral body stenting (1)
- Vertebral fracture (1)
- Vesicles (1)
- Viral load (1)
- Warburg effect (1)
- Weltstadt (1)
- WoMo score (1)
- X-ray crystallography (1)
- Xenon-based gas mixture (1)
- Zuckerkandl’s tubercle (1)
- Zwangseinweisungen (1)
- accident (1)
- acneiform skin toxicity (1)
- acoustic radiation force impulse imaging (1)
- acute coronary syndromes (1)
- acute‐on‐chronic liver failure (1)
- adjuvant chemotherapy (1)
- adoptive cancer immunotherapy (1)
- adrenal insuffciency (1)
- advanced breast cancer (1)
- advanced melanoma (1)
- agaricomycetes (1)
- age (1)
- age-related macular degeneration (1)
- alirocumab (1)
- alleles (1)
- amphiregulin (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- angiogenesis (1)
- angiopoietin-2 (1)
- antibiotic (1)
- anticonvulsants (1)
- antifungal agents (1)
- antifungals (1)
- antihormone therapy (1)
- antiviral therapy (1)
- apoptosis (1)
- aridity (1)
- astrocytoma (1)
- autism spectrum disorder (1)
- autistic disorder (1)
- autophagy (1)
- axions (1)
- biogeographic legaciese (1)
- biologicals (1)
- biomarkers (1)
- biosecurity (1)
- bone marrow metastasis (1)
- bone metastasis (1)
- bronchial epithelium (1)
- burkholderia (1)
- burkholderia cepacia complex infections (1)
- c-kit (1)
- calorimeter: electromagnetic (1)
- cancer immunotherapy (1)
- capture (1)
- cell therapy (1)
- cell transplantation (1)
- cellular therapy (1)
- cerebral pseudoprogression (1)
- cerebral radiation necrosis (1)
- cerebrospinal fluid (1)
- cerium (1)
- cetuximab-bevacizumab therapy sequence (1)
- chemogenomic set (1)
- children and adolescents (1)
- chronic viral hepatitis (1)
- circulation (1)
- climate gradient (1)
- clinical trial (1)
- clonal transfer (1)
- co-infection (1)
- colon carcinoma (1)
- complementary psychosocial care (1)
- complete response (1)
- concept (1)
- conservation (1)
- continuum model (1)
- copy number polymorphism (1)
- cross-section (1)
- cryo-EM (1)
- cryopreservation (1)
- cystic fibrosis (1)
- cytotoxic T cells (1)
- dE/dx (1)
- dabrafenib (1)
- dark matter experiments (1)
- dental implants (1)
- detector (1)
- dexamethasone (1)
- diffusion-weighted magnetic resonance imaging (1)
- digestion artifact (1)
- discomfort/pain (1)
- discontinuation (1)
- disease outbreaks (1)
- disease prevalence (1)
- disease progression (1)
- domestication (1)
- doxycycline (1)
- drug discovery (1)
- druggable genome (1)
- early childhood (1)
- ectosomes (1)
- elderly (1)
- elderly patients (1)
- electronics: readout (1)
- electrophoresis (1)
- emergency care (1)
- endemisch (1)
- epidermal growth factor receptor (1)
- epilepsy (1)
- epiregulin (1)
- everolimus (1)
- evolution (1)
- ex vivo expansion (1)
- exosomes (1)
- exotic (1)
- experimental results (1)
- expertise (1)
- extracellular vesicles (1)
- familial amyloid nephropathy with urticaria and deafness (1)
- fibre: optical (1)
- fibrotest (1)
- focused electron beam induced deposition (1)
- forest classification (1)
- forest functional similarity (1)
- fragment screening (1)
- fresh frozen plasma (1)
- freshwater ecosystems (1)
- functional connectivity (1)
- fungal infection (1)
- galunisertib monohydrate (LY2157299) (1)
- gamma (1)
- gel (1)
- gene flow (1)
- genes (1)
- genetics (1)
- genotype (1)
- genotype determination (1)
- geriatric medicine (1)
- germ cell tumors (1)
- glioblastoma survival (1)
- glioma microenvironment (1)
- gliomas (1)
- gliomatosis cerebri growth pattern (1)
- glycolysis (1)
- guidelines (1)
- habitat destruction (1)
- heavy ion experiments (1)
- hemodynamic (1)
- hepatitis c (1)
- high-dose chemotherapy (1)
- histology (1)
- histopathological growth pattern (1)
- human (1)
- hydrocephalus (1)
- hyperalgesia (1)
- hypoxia-induced cell death (1)
- immune checkpoint blockade (1)
- immune checkpoint inhibitors (1)
- immune checkpoint inhibitors (ICI) (1)
- immune infiltration (1)
- immune related adverse events (irAE) (1)
- immune response (1)
- impact (1)
- inducible gene expression (1)
- infections (1)
- infiltration (1)
- inflammation (1)
- injury (1)
- insect abundance (1)
- inter-individual variability (1)
- interim positron emissiontomography (1)
- intraventricular chemotherapy (1)
- invasion (1)
- invasive growth (1)
- investigational (1)
- involuntary hospitalization (1)
- isocaloric ketogenic diet (1)
- isovaleric acidaemia (1)
- kidney function (1)
- kinase inhibitor (1)
- land use (1)
- lapatinib (1)
- leptomeningeal disease (1)
- leptomeningeal metastases (1)
- leukopenia (1)
- liver metastasis (1)
- lockdown (1)
- long-term protection (1)
- long-term research (1)
- long36 term protection (1)
- low-density lipoprotein cholesterol (1)
- lymphoma (1)
- mTOR inhibition (1)
- magentoencephalography (MEG) (1)
- magnetic resonance imaging (1)
- magnetoencephalography (1)
- major adverse cardiovascular events (1)
- malignant glioma (1)
- management (1)
- marked lymph node (1)
- mass spectrometry (1)
- medical device (1)
- medulloblastoma (1)
- melanoma (1)
- membrane proteins (1)
- mental health services (1)
- mentalizing (1)
- metabolic cancer therapy (1)
- metabolism (1)
- metastasis (1)
- metastatic renal cell carcinoma (1)
- microbial colonization (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- moisturing cream (1)
- molecular machines (1)
- mouthwash (1)
- mouthwash solution (1)
- multifocal (1)
- multiplexed immunofluorescence (1)
- murine model (1)
- n_TOF (1)
- native (1)
- natural killer cells (1)
- neoadjuvant chemoradiotherapy (1)
- neoadjuvant immunochemotherapy (1)
- neuroblastoma (1)
- neurodegeneration (1)
- neuroimaging (1)
- neurological complication (1)
- neurological side effects (1)
- neutron (1)
- neutropenia (1)
- nitrogen (1)
- nivolumab (1)
- nociceptors (1)
- nodular lymphocyte-predominant Hodgkin lymphoma (1)
- non-invasive fibrosis assessment (1)
- nonnative (1)
- nuclear receptor (1)
- nucleoside analysis (1)
- nucleosynthesis (1)
- nutrient availability (1)
- omega stringer (1)
- open guided waves (1)
- oral cavity cancer (1)
- oscillation (1)
- outbreak (1)
- ovary (1)
- p+p collisions (1)
- p47phox (1)
- pSMAD2 (1)
- patterns of progression (1)
- pediatric cancer (1)
- pediatric intensive care (1)
- pembrolizumab (1)
- perception (1)
- perceptual closure (1)
- perceptual organization (1)
- pericytes (1)
- periodontal probing, (1)
- perioperative ischemia (1)
- peritumoral edema (1)
- peritumoral edema zone (1)
- peri‐implant probing (1)
- pertuzumab (1)
- phase IV (1)
- phenotype (1)
- phenotypic screening (1)
- phosphorus (1)
- phylogenetic community distance (1)
- phylogeny (1)
- phytometer (1)
- pivalate (1)
- pivoloyl (1)
- plant productivity (1)
- platelet lysate (1)
- platform switching (1)
- pleomorphic xanthoastrocytoma (1)
- point shear wave elastography (1)
- pole concept of goiter growth (1)
- polyacetylenes (1)
- polyines (1)
- polymorphism (1)
- polyynes (1)
- portal hypertension (1)
- post-transplantation lymphoproliferative disease (1)
- posterior horn (1)
- posteroinferior horn (1)
- precision weighting (1)
- precursor residence time (1)
- predictive biomarker (1)
- predictive biomarkers (1)
- predictive coding (1)
- pressure cycling technology (1)
- primary active transporters (1)
- primary brain tumors (1)
- primary immunodeficiency (PID) (1)
- prognosis (1)
- prophylaxis (1)
- proprotein convertase subtilisin/kexin type 9 inhibition (1)
- prosocial behavior (1)
- protein kinase (1)
- proteome (1)
- pulmonary embolism (1)
- pulsed-field (1)
- quark gluon plasma (1)
- radiotherapy (1)
- randomized (1)
- recurrence pattern (1)
- red blood cells (1)
- reference damage (1)
- registry for primary immunodeficiency (1)
- regorafenib (1)
- regorafenib csf concentration (1)
- renin-angiotensin system (1)
- repetition suppression (RS) (1)
- reproducibility (1)
- resource limitation (1)
- respiratory infections (1)
- retinoid X receptor (1)
- rhabdomyosarcoma (1)
- rhinovirus (1)
- rigor (1)
- risk factor progression (1)
- risk factors (1)
- risk of malignancy (1)
- s-process (1)
- sEH (1)
- scanning laser Doppler vibrometry (1)
- second-line (1)
- second-line immunotherapy (1)
- seizures (1)
- sequence alignment (1)
- sex (1)
- signal processing (1)
- simulation (1)
- simulation training (1)
- single nucleotide polymorphism (1)
- single subject classification (1)
- small molecule inhibitor (1)
- small molecules (1)
- social exclusion (1)
- social psychiatry (1)
- soft tissue sarcoma (1)
- solar physics (1)
- spectra (1)
- stability (1)
- stage II/III colorectal cancer (1)
- stakeholder (1)
- standardization (1)
- stearic acid (1)
- stereotactic radiosurgery (1)
- structural biology (1)
- structural health monitoring (1)
- subgrouping (1)
- surgery (1)
- synaesthesia (1)
- synchronization (1)
- synchrony (1)
- taller-than-wide (1)
- targeted axillary dissection (1)
- temozolomide (1)
- temporal classification (1)
- testis (1)
- tetracycline (1)
- theory of mind (1)
- therapeutic anticoagulation (1)
- therapy (1)
- therapy response (1)
- threats (1)
- thrombolysis (1)
- thrombolysis (tPA) (1)
- training (1)
- transfusion (1)
- transient elastography (1)
- trastuzumab (1)
- trauma (1)
- treatment resistance (1)
- tropical forests (1)
- tumor (1)
- tumor metabolism (1)
- tumor necrosis factor receptor superfamily member 9 (1)
- tumor-infiltrating lymphocytes (1)
- uncertainty (1)
- understudied kinase (1)
- uveal melanoma (1)
- valuation (1)
- vascular endothelial growth factor (1)
- vascular endothelial growth factor receptor (1)
- ventriculoperitoneal shunt (1)
- vessel-associated mural cells (1)
- visual priming (1)
- white and brown dwarfs (1)
- women (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1209)
- Frankfurt Institute for Advanced Studies (FIAS) (1005)
- Informatik (922)
- Medizin (225)
- Geowissenschaften (16)
- Biowissenschaften (13)
- Biochemie und Chemie (11)
- Senckenbergische Naturforschende Gesellschaft (8)
- Institut für Ökologie, Evolution und Diversität (6)
- Biochemie, Chemie und Pharmazie (5)
Background: Hypoxia is a key driver for infiltrative growth in experimental gliomas. It has remained elusive whether tumor hypoxia in glioblastoma patients contributes to distant or diffuse recurrences. We therefore investigated the influence of perioperative cerebral ischemia on patterns of progression in glioblastoma patients.
Methods: We retrospectively screened MRI scans of 245 patients with newly diagnosed glioblastoma undergoing resection for perioperative ischemia near the resection cavity. 46 showed relevant ischemia nearby the resection cavity. A control cohort without perioperative ischemia was generated by a 1:1 matching using an algorithm based on gender, age and adjuvant treatment. Both cohorts were analyzed for patterns of progression by a blinded neuroradiologist.
Results: The percentage of diffuse or distant recurrences at first relapse was significantly higher in the cohort with perioperative ischemia (61.1%) compared to the control cohort (19.4%). The results of the control cohort matched well with historical data. The change in patterns of progression was not associated with a difference in survival.
Conclusions: This study reveals an unrecognized association of perioperative cerebral ischemia with distant or diffuse recurrence in glioblastoma. It is the first clinical study supporting the concept that hypoxia is a key driver of infiltrative tumor growth in glioblastoma patients.
Radiographic and safety details of vertebral body stenting : results from a multicenter chart review
(2013)
Background: Up to one third of BKP treated cases shows no appreciable height restoration due to loss of both restored height and kyphotic realignment after balloon deflation. This shortcoming has called for an improved method that maintains the height and realignment reached by the fully inflated balloon until stabilization of the vertebral body by PMMA-based cementation. Restoration of the physiological vertebral body height for pain relief and for preventing further fractures of adjacent and distant vertebral bodies must be the main aim for such a method. A new vertebral body stenting system (VBS) stabilizes the vertebral body after balloon deflation until cementation. The radiographic and safety results of the first 100 cases where VBS was applied are presented.
Methods: During the planning phase of an ongoing international multicenter RCT, radiographic, procedural and followup details were retrospectively transcribed from charts and xrays for developing and testing the case report forms. Radiographs were centrally assessed at the institution of the first/senior author.
Results: 100 patients (62 with osteoporosis) with a total of 103 fractured vertebral bodies were treated with the VBS system. 49 were females with a mean age of 73.2 years; males were 66.7 years old. The mean preoperative anterior-middle-posterior heights were 20.3-17.6-28.0 mm, respectively. The mean local kyphotic angle was 13.1°. The mean preoperative Beck Index (anterior edge height/posterior edge height) was 0.73, the mean alternative Beck Index (middle height/posterior edge height) was 0.63. The mean postoperative heights were restored to 24.5-24.6-30.4 mm, respectively. The mean local kyphotic angle was reduced to 8.9°. The mean postoperative Beck Index was 0.81, the mean alternative one was 0.82. The overall extrusion rate was 29.1%, the symptomatic one was 1%. In the osteoporosis subgroup there were 23.8% extrusions. Within the three months followup interval there were 9% of adjacent and 4% of remote new fractures, all in the osteoporotic group.
Conclusions: VBS showed its strengths especially in realignment of crush and biconcave fractures. Given that fracture mobility is present, the realignment potential is sound and increases with the severity of preoperative vertebral body deformation.
In relativistic heavy-ion collisions, a global spin polarization, PH, of Λ and Λ¯ hyperons along the direction of the system angular momentum was discovered and measured across a broad range of collision energies and demonstrated a trend of increasing PH with decreasing sNN−−−√. A splitting between Λ and Λ¯ polarization may be possible due to their different magnetic moments in a late-stage magnetic field sustained by the quark-gluon plasma which is formed in the collision. The results presented in this study find no significant splitting at the collision energies of sNN−−−√=19.6 and 27 GeV in the RHIC Beam Energy Scan Phase II using the STAR detector, with an upper limit of PΛ¯−PΛ<0.24% and PΛ¯−PΛ<0.35%, respectively, at a 95% confidence level. We derive an upper limit on the naïve extraction of the late-stage magnetic field of B<9.4⋅1012 T and B<1.4⋅1013 T at sNN−−−√=19.6 and 27 GeV, respectively, although more thorough derivations are needed. Differential measurements of PH were performed with respect to collision centrality, transverse momentum, and rapidity. With our current acceptance of |y|<1 and uncertainties, we observe no dependence on transverse momentum and rapidity in this analysis. These results challenge multiple existing model calculations following a variety of different assumptions which have each predicted a strong dependence on rapidity in this collision-energy range.
In relativistic heavy-ion collisions, a global spin polarization, PH, of Λ and Λ¯ hyperons along the direction of the system angular momentum was discovered and measured across a broad range of collision energies and demonstrated a trend of increasing PH with decreasing sNN−−−√. A splitting between Λ and Λ¯ polarization may be possible due to their different magnetic moments in a late-stage magnetic field sustained by the quark-gluon plasma which is formed in the collision. The results presented in this study find no significant splitting at the collision energies of sNN−−−√=19.6 and 27 GeV in the RHIC Beam Energy Scan Phase II using the STAR detector, with an upper limit of PΛ¯−PΛ<0.24% and PΛ¯−PΛ<0.35%, respectively, at a 95% confidence level. We derive an upper limit on the naïve extraction of the late-stage magnetic field of B<9.4⋅1012 T and B<1.4⋅1013 T at sNN−−−√=19.6 and 27 GeV, respectively, although more thorough derivations are needed. Differential measurements of PH were performed with respect to collision centrality, transverse momentum, and rapidity. With our current acceptance of |y|<1 and uncertainties, we observe no dependence on transverse momentum and rapidity in this analysis. These results challenge multiple existing model calculations following a variety of different assumptions which have each predicted a strong dependence on rapidity in this collision-energy range.
In relativistic heavy-ion collisions, a global spin polarization, PH, of Λ and Λ¯ hyperons along the direction of the system angular momentum was discovered and measured across a broad range of collision energies and demonstrated a trend of increasing PH with decreasing sNN−−−√. A splitting between Λ and Λ¯ polarization may be possible due to their different magnetic moments in a late-stage magnetic field sustained by the quark-gluon plasma which is formed in the collision. The results presented in this study find no significant splitting at the collision energies of sNN−−−√=19.6 and 27 GeV in the RHIC Beam Energy Scan Phase II using the STAR detector, with an upper limit of PΛ¯−PΛ<0.24% and PΛ¯−PΛ<0.35%, respectively, at a 95% confidence level. We derive an upper limit on the naïve extraction of the late-stage magnetic field of B<9.4⋅1012 T and B<1.4⋅1013 T at sNN−−−√=19.6 and 27 GeV, respectively, although more thorough derivations are needed. Differential measurements of PH were performed with respect to collision centrality, transverse momentum, and rapidity. With our current acceptance of |y|<1 and uncertainties, we observe no dependence on transverse momentum and rapidity in this analysis. These results challenge multiple existing model calculations following a variety of different assumptions which have each predicted a strong dependence on rapidity in this collision-energy range.
Elliptic flow of heavy-flavor decay electrons in Au+Au collisions at √sNN = 27 and 54.4 GeV at RHIC
(2023)
We report on new measurements of elliptic flow (v2) of electrons from heavy-flavor hadron decays at mid-rapidity (|y|<0.8) in Au+Au collisions at sNN−−−√ = 27 and 54.4 GeV from the STAR experiment. Heavy-flavor decay electrons (eHF) in Au+Au collisions at sNN−−−√ = 54.4 GeV exhibit a non-zero v2 in the transverse momentum (pT) region of pT< 2 GeV/c with the magnitude comparable to that at sNN−−−√=200 GeV. The measured eHF v2 at 54.4 GeV is also consistent with the expectation of their parent charm hadron v2 following number-of-constituent-quark scaling as other light and strange flavor hadrons at this energy. These suggest that charm quarks gain significant collectivity through the evolution of the QCD medium and may reach local thermal equilibrium in Au+Au collisions at sNN−−−√=54.4 GeV. The measured eHF v2 in Au+Au collisions at sNN−−−√= 27 GeV is consistent with zero within large uncertainties. The energy dependence of v2 for different flavor particles (π,ϕ,D0/eHF) shows an indication of quark mass hierarchy in reaching thermalization in high-energy nuclear collisions.
Elliptic flow of heavy-flavor decay electrons in Au+Au collisions at √sNN = 27 and 54.4 GeV at RHIC
(2023)
We report on new measurements of elliptic flow (v2) of electrons from heavy-flavor hadron decays at mid-rapidity (|y|<0.8) in Au+Au collisions at sNN−−−√ = 27 and 54.4 GeV from the STAR experiment. Heavy-flavor decay electrons (eHF) in Au+Au collisions at sNN−−−√ = 54.4 GeV exhibit a non-zero v2 in the transverse momentum (pT) region of pT< 2 GeV/c with the magnitude comparable to that at sNN−−−√=200 GeV. The measured eHF v2 at 54.4 GeV is also consistent with the expectation of their parent charm hadron v2 following number-of-constituent-quark scaling as other light and strange flavor hadrons at this energy. These suggest that charm quarks gain significant collectivity through the evolution of the QCD medium and may reach local thermal equilibrium in Au+Au collisions at sNN−−−√=54.4 GeV. The measured eHF v2 in Au+Au collisions at sNN−−−√= 27 GeV is consistent with zero within large uncertainties. The energy dependence of v2 for different flavor particles (π,ϕ,D0/eHF) shows an indication of quark mass hierarchy in reaching thermalization in high-energy nuclear collisions.
Density fluctuations near the QCD critical point can be probed via an intermittency analysis in relativistic heavy-ion collisions. We report the first measurement of intermittency in Au+Au collisions at sNN−−−√ = 7.7-200 GeV measured by the STAR experiment at the Relativistic Heavy Ion Collider (RHIC). The scaled factorial moments of identified charged hadrons are analyzed at mid-rapidity and within the transverse momentum phase space. We observe a power-law behavior of scaled factorial moments in Au+Au collisions and a decrease in the extracted scaling exponent (ν) from peripheral to central collisions. The ν is consistent with a constant for different collisions energies in the mid-central (10-40\%) collisions. Moreover, the ν in the 0-5\% most central Au+Au collisions exhibits a non-monotonic energy dependence that reaches a possible minimum around sNN−−−√ = 27 GeV. The physics implications on the QCD phase structure are discussed.
Density fluctuations near the QCD critical point can be probed via an intermittency analysis in relativistic heavy-ion collisions. We report the first measurement of intermittency in Au+Au collisions at √sNN = 7.7-200 GeV measured by the STAR experiment at the Relativistic Heavy Ion Collider (RHIC). The scaled factorial moments of identified charged hadrons are analyzed at mid-rapidity and within the transverse momentum phase space. We observe a power-law behavior of scaled factorial moments in Au+Au collisions and a decrease in the extracted scaling exponent (ν) from peripheral to central collisions. The ν is consistent with a constant for different collisions energies in the mid-central (10-40%) collisions. Moreover, the ν in the 0-5% most central Au+Au collisions exhibits a non-monotonic energy dependence that reaches a minimum around √sNN = 27 GeV. The physics implications on the QCD phase structure are discussed.
We measure triangular flow relative to the reaction plane at 3 GeV center-of-mass energy in Au+Au collisions at the BNL Relativistic Heavy Ion Collider. A significant v3 signal for protons is observed, which increases for higher rapidity, higher transverse momentum, and more peripheral collisions. The triangular flow is essentially rapidity-odd with a slope at mid-rapidity, dv3/dy|(y=0), opposite in sign compared to the slope for directed flow. No significant v3 signal is observed for charged pions and kaons. Comparisons with models suggest that a mean field potential is required to describe these results, and that the triangular shape of the participant nucleons is the result of stopping and nuclear geometry.
The longitudinal and transverse spin transfers to Λ (Λ¯¯¯¯) hyperons in polarized proton-proton collisions are expected to be sensitive to the helicity and transversity distributions, respectively, of (anti-)strange quarks in the proton, and to the corresponding polarized fragmentation functions. We report improved measurements of the longitudinal spin transfer coefficient, DLL, and the transverse spin transfer coefficient, DTT, to Λ and Λ¯¯¯¯ in polarized proton-proton collisions at s√ = 200 GeV by the STAR experiment at RHIC. The data set includes longitudinally polarized proton-proton collisions with an integrated luminosity of 52 pb−1, and transversely polarized proton-proton collisions with a similar integrated luminosity. Both data sets have about twice the statistics of previous results and cover a kinematic range of |ηΛ(Λ¯¯¯¯)| < 1.2 and transverse momentum pT,Λ(Λ¯¯¯¯) up to 8 GeV/c. We also report the first measurements of the hyperon spin transfer coefficients DLL and DTT as a function of the fractional jet momentum z carried by the hyperon, which can provide more direct constraints on the polarized fragmentation functions.
The longitudinal and transverse spin transfers to Λ (Λ¯¯¯¯) hyperons in polarized proton-proton collisions are expected to be sensitive to the helicity and transversity distributions, respectively, of (anti-)strange quarks in the proton, and to the corresponding polarized fragmentation functions. We report improved measurements of the longitudinal spin transfer coefficient, DLL, and the transverse spin transfer coefficient, DTT, to Λ and Λ¯¯¯¯ in polarized proton-proton collisions at s√ = 200 GeV by the STAR experiment at RHIC. The data set includes longitudinally polarized proton-proton collisions with an integrated luminosity of 52 pb−1, and transversely polarized proton-proton collisions with a similar integrated luminosity. Both data sets have about twice the statistics of previous results and cover a kinematic range of |ηΛ(Λ¯¯¯¯)| < 1.2 and transverse momentum pT,Λ(Λ¯¯¯¯) up to 8 GeV/c. We also report the first measurements of the hyperon spin transfer coefficients DLL and DTT as a function of the fractional jet momentum z carried by the hyperon, which can provide more direct constraints on the
We report results on an elastic cross section measurement in proton-proton collisions at a center-of-mass energy s√=510 GeV, obtained with the Roman Pot setup of the STAR experiment at the Relativistic Heavy Ion Collider (RHIC). The elastic differential cross section is measured in the four-momentum transfer squared range 0.23≤−t≤0.67 GeV2. We find that a constant slope B does not fit the data in the aforementioned t range, and we obtain a much better fit using a second-order polynomial for B(t). The t dependence of B is determined using six subintervals of t in the STAR measured t range, and is in good agreement with the phenomenological models. The measured elastic differential cross section dσ/dt agrees well with the results obtained at s√=546 GeV for proton--antiproton collisions by the UA4 experiment. We also determine that the integrated elastic cross section within the STAR t-range is σfidel=462.1±0.9(stat.)±1.1(syst.)±11.6(scale) μb.
We report a new measurement of the production of electrons from open heavy-flavor hadron decays (HFEs) at mid-rapidity (|y| < 0.7) in Au+Au collisions at √sNN = 200 GeV. Invariant yields of HFEs are measured for the transverse momentum range of 3.5 < pT < 9 GeV/c in various configurations of the collision geometry. The HFE yields in head-on Au+Au collisions are suppressed by approximately a factor of 2 compared to that in p + p collisions scaled by the average number of binary collisions, indicating strong interactions between heavy quarks and the hot and dense medium created in heavy-ion collisions. Comparison of these results with models provides additional tests of theoretical calculations of heavy quark energy loss in the quark-gluon plasma.
We report the first measurements of cumulants, up to 4𝑡ℎ order, of deuteron number distributions and protondeuteron correlations in Au+Au collisions recorded by the STAR experiment in phase-I of Beam Energy Scan (BES) program at the Relativistic Heavy Ion Collider. Deuteron cumulants, their ratios, and proton-deuteron mixed cumulants are presented for different collision centralities covering a range of center-of-mass energy per nucleon pair √𝑠NN = 7.7 to 200 GeV. It is found that the cumulant ratios at lower collision energies favor a canonical ensemble over a grand canonical ensemble in thermal models. An anti-correlation between proton and deuteron multiplicity is observed across all collision energies and centralities, consistent with the expectation from global baryon number conservation. The UrQMD model coupled with a phase-space coalescence mechanism qualitatively reproduces the collision-energy dependence of cumulant ratios and proton-deuteron correlations.
We report the first measurements of cumulants, up to 4th order, of deuteron number distributions and proton-deuteron correlations in Au+Au collisions recorded by the STAR experiment in phase-I of Beam Energy Scan (BES) program at the Relativistic Heavy Ion Collider. Deuteron cumulants, their ratios, and proton-deuteron mixed cumulants are presented for different collision centralities covering a range of center-of-mass energy per nucleon pair sNN−−−−√~=~7.7 to 200~GeV. It is found that the cumulant ratios at lower collision energies favor a canonical ensemble over a grand canonical ensemble in thermal models. An anti-correlation between proton and deuteron multiplicity is observed across all collision energies and centralities, consistent with the expectation from global baryon number conservation. The UrQMD model coupled with a phase-space coalescence mechanism qualitatively reproduces the collision-energy dependence of cumulant ratios and proton-deuteron correlations.
We report a new measurement of the production of electrons from open heavy-flavor hadron decays (HFEs) at mid-rapidity (|y|< 0.7) in Au+Au collisions at sNN−−−√=200 GeV. Invariant yields of HFEs are measured for the transverse momentum range of 3.5<pT<9 GeV/c in various configurations of the collision geometry. The HFE yields in head-on Au+Au collisions are suppressed by approximately a factor of 2 compared to that in p+p collisions scaled by the average number of binary collisions, indicating strong interactions between heavy quarks and the hot and dense medium created in heavy-ion collisions. Comparison of these results with models provides additional tests of theoretical calculations of heavy quark energy loss in the quark-gluon plasma.
We report a new measurement of the production of electrons from open heavy-flavor hadron decays (HFEs) at mid-rapidity (|y|< 0.7) in Au+Au collisions at sNN−−−√=200 GeV. Invariant yields of HFEs are measured for the transverse momentum range of 3.5<pT<9 GeV/c in various configurations of the collision geometry. The HFE yields in head-on Au+Au collisions are suppressed by approximately a factor of 2 compared to that in p+p collisions scaled by the average number of binary collisions, indicating strong interactions between heavy quarks and the hot and dense medium created in heavy-ion collisions. Comparison of these results with models provides additional tests of theoretical calculations of heavy quark energy loss in the quark-gluon plasma.
We report the measurement of K∗0 meson at midrapidity (|y|< 1.0) in Au+Au collisions at sNN−−−√~=~7.7, 11.5, 14.5, 19.6, 27 and 39 GeV collected by the STAR experiment during the RHIC beam energy scan (BES) program. The transverse momentum spectra, yield, and average transverse momentum of K∗0 are presented as functions of collision centrality and beam energy. The K∗0/K yield ratios are presented for different collision centrality intervals and beam energies. The K∗0/K ratio in heavy-ion collisions are observed to be smaller than that in small system collisions (e+e and p+p). The K∗0/K ratio follows a similar centrality dependence to that observed in previous RHIC and LHC measurements. The data favor the scenario of the dominance of hadronic re-scattering over regeneration for K∗0 production in the hadronic phase of the medium.